Navigation Links
32-country study shows that type 2 diabetes drug is clinically effective for long-term use
Date:7/23/2012

An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication.

The 32-country study, published in the August issue of IJCP, the International Journal of Clinical Practice, followed 2,121 individuals who had taken part in four previous 24-week randomised, double-blind, placebo controlled trials, in order to monitor them for a further 78 weeks.

Those subjects who had previously received linagliptin (1,532) continued to do so and those who had received the placebo during the earlier trials (589) were also given the drug during the 78-week trial extension.

The participants who took part in the extended trial came from 231 sites in 32 countries: Argentina, Austria, Belgium, Canada, China, Croatia, the Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Malaysia, Mexico, the Netherlands, New Zealand, the Philippines, Poland, Romania, Russia, Slovakia, Spain, Sweden, Taiwan, Thailand, Ukraine, the United Kingdom and the United States.

"Initial 24-week trials showed that linagliptin, either on its own or with other glucose-lowering agents, was effective in improving glycaemic control without weight gain or an independent increased risk of hypoglycaemia (reduced blood sugar levels)" says co-author David R Owens, Professor Emeritus, Centre for Endocrinology and Diabetes Sciences at Cardiff University, Wales, UK.

"Linagliptin works by blocking the action of DPP-4, an enzyme that destroys the hormone GLP-1, which helps the body produce more insulin when it is needed." Linagliptin was administered orally once a day in all cases, either on its own, or in combination with metformin or metformin plus a sulphonylurea or pioglitazone.

Key findings of th
'/>"/>

Contact: Annette Whibley
annette.wizard@gmail.com
Wiley
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Neuroeconomics to study decision-making in anxious individuals
2. Study offers new clue on how brain processes visual information
3. Not All HIV Patients in U.S. Show Same Characteristics: Study
4. Women With HIV May Not Have Higher Cervical Cancer Risk: Study
5. HIV suppression not as good as previously thought, largest study of viral-load blood tests show
6. Benefits of HIV drugs rise -- but less than previously believed, Penn study shows
7. Study examines characteristics, risk factors among HIV-positive persons born outside the US
8. Vitamin D May Delay Deterioration of Smokers Lungs: Study
9. Biology Leaves Gay Men Highly Vulnerable to HIV: Study
10. Older Americans See Better Today, Study Finds
11. Autumn Birthday Ups Odds of Living to 100: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... The premier online medical ... become a leader in podiatric, surgical and wound care conferences . The ... top national speakers at the podium and across the table during hands-on surgical ...
(Date:8/31/2015)... ... September 01, 2015 , ... ... back pain – once required a long, arduous recovery. However, today’s minimally invasive ... pain, less blood loss and minimal muscle damage. These advantages of minimally invasive ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... include a wealth of information for specific translation services within the medical and ... an incredible track record of successful work. , ITC Global Translations specializes in ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article based on a ... addressed the topic of treating back pain caused by a disrupted disk by using ... slightly improve physical function in patients suffering from a herniated disk, the level of ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence ... is unique to the Lake Orion area. This program is one of the ... WEmovestrong’s weight management program will incorporate group fitness and nutritional consultations to help ...
Breaking Medicine News(10 mins):Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2
... ... (AAE) for the second consecutive year. , ... Macau (PRWEB) June 28, 2009 -- Macau.com, the leading online destination marketing and ... Expo (AAE) for the second consecutive year., , , , ,As one of the ...
... ... This new web site, produced by a team of doctors and powered by a new ... for trusted health information in an accessible format that explains the medical meaning behind the ... Boston, MA (PRWEB) ...
... differentiate between healthy and abnormal cells , FRIDAY, June 26 ... sniff out cancer with a "chemical nose," a new report ... University of Massachusetts at Amherst say they have developed highly ... of a cell that indicate if it is healthy or ...
... ... 2009 American Orthopaedic Society for Sports Medicine (AOSSM) Hall of Fame inductees. , ... Keystone, CO (PRWEB) June 27, 2009 -- Giancarlo ... Hall of Fame inductees. Chosen for his vast research and instruction on knee surgery, Dr. Puddu ...
... intake of dietary fats from red meat and dairy products ... to a new study published online June 26 in the ... This study was undertaken because research relating fat intake to ... Z. Stolzenberg-Solomon, Ph.D., of the Division of Cancer Epidemiology and ...
... June 26 Marcus Rayner, executive director of the ... of individuals, businesses and organizations dedicated to improving the ... in the legislature and in the courts, today issued ... the company will immediately discontinue Accutane(R), a treatment for ...
Cached Medicine News:Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 3Health News:Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com 2Health News:Michael Jackson Get the Medical Facts Behind the Headlines at CelebrityDiagnosis.com 3Health News:'Chemical Nose' May Sniff Out Cancer Earlier 2Health News:Internationally Renowned Orthopaedic Surgeon, Giancarlo Puddu, MD, Inducted into Sports Medicine Hall of Fame 2Health News:Dietary fat linked to pancreatic cancer 2
(Date:8/31/2015)... HARRISBURG, Pa. , Aug. 31, 2015  The ... held an event today at Gaudenzia Concept 90 to ... the drug overdose crisis in Pennsylvania ... get treatment and focus on recovery through the ... too many Pennsylvanians are dying every day to a ...
(Date:8/31/2015)... DIEGO , Aug. 31, 2015 Regen ... today development of a novel means of delivering ... acid, RGBP-248, to liver tumors utilizing a clinically ... development overcomes previous hurdles with gene silencing therapeutics ... be delivered throughout the whole body.  By utilizing ...
(Date:8/31/2015)... TEL AVIV, Israel , August 31, 2015 ... Investments Ltd. (TASE: BOLT, OTCQX: BLGTY) ("BioLight" ... manages and commercializes biomedical innovations in ophthalmology and ... subsidiary, Micromedic Technologies (TASE: MCTC), has identified several ... necrosis of the jawbone in patients treated with ...
Breaking Medicine Technology:Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4
... organizer UBM Live announced strong booking levels ... buyers and sellers of high value chemistry. 248 exhibitors ... takes place from February 19th to 22nd of 2013 ... fine and specialty chemical companies that have signed up ...
... 15, 2012  Adamas Pharmaceuticals, Inc., a privately held ... End-of-Phase 2 meeting with the FDA to discuss ... conducted for the registration of Arimenda (memantine HCl ... once-daily fixed dose combination of extended release memantine ...
Cached Medicine Technology:Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 2Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™ 3
... All Infectious Disease ELISA ... well format. Also included ... positive and negative controls, ... stop solution. Use an ...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
... chain reaction (PCR) technology, the worlds leading ... component of Roches blood screening assays and ... of selected unique regions of genetic material ... (that is, to detectable levels) in only ...
The OneTouch Flexx Professional Blood Glucose Monitoring System with OneTouchPro Test Strips sets the standard for safety and convenience with unique off-meter sample application and a wide range of ...
Medicine Products: